spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Amarin Corp 

 HSMN NewsFeed - 10 Sep 2024
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 8 Sep 2016
Albireo Appoints Dr. Paresh N. Soni as Chief Medical Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2014
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2013
Amarin Announces Leadership Changes
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 24 Jan 2013
Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 30 Jan 2012
ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Nov 2011
Amarin Announces Resignation of David Feigal from Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2011
Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2010
Amarin's AMR101 Meets Pivotal Phase 3 Study Endpoints With Highly Statistically Significant Reductions in Triglycerides at 4 Gram and 2 Gram Doses in MARINE Trial With No Statistically Significant Increase in LDL-C and Safety Profile Similar to Placebo
Biopharmaceuticals
 HSMN NewsFeed - 10 Nov 2010
Amarin Corporation Announces Senior Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
OrbiMed Expands Private Equity Team
Venture Capital Personnel
 HSMN NewsFeed - 17 Aug 2010
Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2009
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 6 Nov 2009
Amarin Appoints John F. Thero as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2009
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2008
Amarin Appoints Dr. Paresh Soni as SVP and Head of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Dec 2007
Amarin Announces Management Changes Including Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2007
Amarin Signs Agreement to Acquire Ester Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 19 Nov 2007
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Oct 2007
Amarin Announces Initiation of Cardiovascular Development Strategy
Biopharmaceuticals
 HSMN NewsFeed - 4 Oct 2007
Declan P. Doogan, M.D. Joins IRX Therapeutics as Advisor on Global Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2007
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Apr 2007
Amarin Appoints Declan Doogan to New Position of President-Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2007
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2007
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
Biopharmaceuticals Drug Delivery Neurology Licensing
 HSMN NewsFeed - 27 Feb 2007
Amarin Appoints Professor William Hall as Non-Executive Director
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Feb 2007
Amarin Announces Completion of Two Phase III Trials With Miraxion in Huntington's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Oct 2006
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
Devices Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Jun 2006
Amarin Completes Target Patient Enrollment in North American Phase III Trial of Miraxion(TM) in Huntington's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 May 2006
Amarin Acquires Parkinson's Disease Drug Candidate
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 17 May 2006
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 14

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 14 additional stories matching:
Amarin Corp
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.